Key Takeaways
- Host Ross Butler points to five consecutive down years in global private capital fundraising, but Rede Partners co-founder Adam Turtle rejects the popular excuse that LPs lack cash.
- Public equity markets remain near record highs, which removes the denominator effect as a credible explanation for slow LP commitments.
- Underperformance across the 2020 to 2022 fund vintages has forced institutional investors to overhaul how they underwrite fund managers.
- LPs are dismantling a decade-old consensus that automatically favored enterprise SaaS and healthcare, redirecting capital toward defence, AI-resilient businesses, and middle-market buyouts.
The Denominator Excuse Is Dead
When private equity fundraising drops for five straight years, general partners usually blame the math. The standard pitch to advisory committees claims institutional LPs are tapped out, paralyzed by the denominator effect, or waiting for liquidity before writing fresh checks. Turtle sees through that defense.
“The truth is we're not in a period where there's a massive capital squeeze,” Turtle says. “There's no denominator effect. The public markets are riding high.” When public equities trade at elevated valuations, LP allocations to alternative assets expand on paper rather than contract. Institutional investors have room in their target allocations to commit capital today. They simply choose not to hand it to the same managers.
Instead of a mechanical capital shortage, the slowdown reflects buyer caution. LPs are nursing losses or flat marks from the peak of the market. “The overall performance in those vintages is reasonably disappointing,” Turtle observes regarding the 2020 through 2022 fund cycles, “and certainly disappointing versus what the investors were hoping to receive from those vintages.” The easy money era masked flawed underwriting, and institutions are now living with the hangover.
The Whitelist Collapses
For nearly a decade, raising a private equity fund followed a predictable formula. Pitch recurring revenue software or roll-up healthcare, show top-line growth, and LPs would back the vehicle. That consensus has fractured.
“On the LP side, we're in a really interesting period in the market because for the last certainly for the last 10 years, there have been certain prevailing orthodoxies about which segments are almost whitelisted for investment from a sectoral perspective that have been somewhat undermined over the last 12 months or so,” Turtle notes. Enterprise software, once treated as bulletproof, now faces scrutiny over AI exposure and customer budget cuts. Healthcare platforms face wage inflation, regulatory pushback, and debt service pressures.
As the old safe havens lose their automatic green light, allocators are rotating into areas they avoided during the bull run. Capital is migrating toward defence technology, infrastructure assets, and lower-middle-market buyouts where entry multiples never reached tech-bubble heights. In Turtle's view, the market is living through a classic clearing event: “We're also in a period which I think best links to that great Warren Buffett quote about the tide going out and you see who's wearing shorts.”
Diligence Replaces Distribution
The immediate consequence for sponsors is a grinding diligence cycle. When LPs re-examine their portfolio balance, they do not just switch sectors; they slow their entire pacing model. “There's this sort of strategic realignment of appetite which clearly has an impact on the speed of their investment behavior,” Turtle explains.
Fund placement can no longer rely on personal rolodexes or superficial roadshows. Institutional allocators are interrogating GP track records on a deal-by-deal basis, testing whether historical returns came from leverage and multiple expansion or genuine operational growth. They are scrutinizing fund terms, assessing manager exposure to GP stakes, and questioning whether elevated hurdle rates truly align incentives. Capital is available, but the hurdle to access it is higher than at any point in the past decade.
Why It Matters
This capital dynamic signals that the private equity fundraising drought will not self-correct through public market rallies or lower interest rates alone. LPs are re-underwriting the entire private asset class, separating managers with genuine operating capability from financial engineering shops. Sponsors still relying on peak-cycle playbooks, particularly in large-cap software, will face extended closes or failed fundraises while disciplined middle-market and defence-focused strategies absorb the remaining institutional allocations.